[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100640961":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":27,"centralContacts":37,"locations":43,"responsibleParty":61,"collaborators":64,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":27,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":76,"maxAge":27,"enrollmentInfo":77,"targetDuration":27,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":88,"overallStatus":91,"whyStopped":27,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Columbia University","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Post-operative Steroids","ACTIVE_COMPARATOR","Participants will receive a 5-day regimen of 40 mg oral prednisone postoperatively.",[13,14,15],"Drug: Prednisone","Device: Continuous Glucose Monitor","Other: InkWell Health Tattoos",{"label":17,"type":18,"description":19,"interventionNames":20},"Standard of care","PLACEBO_COMPARATOR","Participants will receive standard of care treatment, consisting of the intravenous administration of dexamethasone and periarticular administration of steroids intraoperatively.",[14,15],[22,28,33],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"DRUG","Prednisone","40 mg daily for 5 days",[9],null,{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":27},"DEVICE","Continuous Glucose Monitor","Provides real-time glucose readings for up to 14 days",[9,17],{"type":6,"name":34,"description":35,"armGroupLabels":36,"otherNames":27},"InkWell Health Tattoos","Temporary medical-grade tattoos that provide real-time monitoring of knee swelling and range of motion",[9,17],[38],{"name":39,"role":40,"phone":41,"phoneExt":27,"email":42},"Jacqueline Lenahan","CONTACT","(212) 305-8193","jl5092@cumc.columbia.edu",[44],{"facility":45,"status":27,"city":46,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Columbia University Irving Medical Center","New York","10032","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-74.00597,40.71427,{"lat":54,"lon":53},[57,59],{"name":58,"role":40,"phone":27,"phoneExt":27,"email":27},"Roshan Shah, MD",{"name":58,"role":60,"phone":27,"phoneExt":27,"email":27},"PRINCIPAL_INVESTIGATOR",{"type":60,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":27,"oldOrganization":27},"Roshan P. Shah","Russell A. Hibbs Associate Professor of Orthopedics in Orthopedic Surgery and in Surgery",[65],{"name":66,"class":67},"Orthopaedic Scientific Research Foundation","UNKNOWN","100640961","phase-4-post-op-prednisone-and-glucose-monitoring-in-tka-100640961",false,"NCT07630896","Post-op Prednisone and Glucose Monitoring in TKA","Postoperative Prednisone Regimen in TKA and Its Effect on Continuous Glucose Levels","Inclusion Criteria:\n\n* Undergoing Primary Unicompartmental Knee Arthroplasty or Total Hip Arthroplasty\n* Age 18 and above\n\nExclusion Criteria:\n\n* Steroid therapy\n* Narcotic use within past 3 months\n* History of corticosteroid intolerance\n* Pregnancy\n* Uncontrolled diabetes\n* Doesn't own smart phone\n\nDrop Criteria:\n\n\\- 2nd dose of IV dexamethasone","ALL","18 Years",{"count":78,"type":79},104,"ESTIMATED","INTERVENTIONAL",[82],"PHASE4","This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.",[85,86,87],"Osteoarthritis","Unicompartmental Knee Arthroplasty","Total Hip Arthroplasty (THA)",[89,24,90],"Post-operative pain","Continuous Glucose Monitoring","NOT_YET_RECRUITING","2026-06-03",{"date":94,"type":95},"2026-06-05","ACTUAL",{"date":97,"type":79},"2026-07-01",{"date":99,"type":79},"2028-03",{"name":5,"class":6},1]